Skip to main content
Knowledge4Policy
Knowledge for policy

Supporting policy with scientific evidence

We mobilise people and resources to create, curate, make sense of and use knowledge to inform policymaking across Europe.

  • Joined 07/02/2024

Uwe HOLZWARTH

Dr. rer. nat. (physics) - Scientific officer,

I obtained my degree in physics in 1989 at the University of Stuttgart and my Ph.D. (Dr. rer. nat.) in 1992 with a work on metal fatigue performed at the Max-Planck-Institute for Metal Research at Stuttgart. I held a research grant at the Institute for Advanced Materials of the JRC in 1994/95 and became assistant professor (C1) at the Institute for Radiation and Nuclear Physics at the University of Bonn in 1995 working on non-destructive materials testing with nuclear methods. I joined the JRC as scientific officer in 1997 working on nuclear fusion materials. With the creation of the Institute for Health and Consumer Protection in 1998 I was in charge of studies on the performance of biomedical materials. In 2000/2001 I studied clinical engineering by correspondence courses at the University of Kaiserslautern and specialised in medical radiation protection technology and medical devices. From 2002 to 2014 I was responsible for the JRC’s cyclotron laboratory and in charge of the management of cyclotron operations for research and for the commercial production of [18F]-FDG in the framework of an industry collaboration. During this period I investigated the production of medical radionuclides and pioneered methods for the radiolabelling of industrially manufactured nanoparticles as radiotracers in nanotoxicology. After the shutdown of the cyclotron in December 2014 I transferred the radiolabelling of nanoparticles to an external cyclotron and continued with radiotracer studies supporting biological experiments. From 2017 until 2022 I was busy with setting up and managing the medical device expert panels required in the conformity assessment of devices by the Medical Device Regulations 2017/745 and 2017/746. Currently I am looking into accelerating the translation and uptake of innovative cancer treatments in clinical practice, especially of molecular radiotherapies.

Contact me

Login to Knowledge4Policy to drop me a line. You'll need a Public Profile, with "Contact Me" turned on. No account? Register.

Help is available.